The FDA told a Louisiana federal court that its mifepristone safety review should finish by March 2027. Telehealth and mail access remain in place for now.
Mifepristone Access by Mail Continues as FDA Tells Louisiana Court Its Safety Review Should Finish by March 2027
by | Oct 9, 2026 | Uncategorized | 0 comments
Recent Comments